Emergent BioSolutions (EBS) Tax Provisions (2011 - 2026)
Emergent BioSolutions' Tax Provisions was -$3.7 million in Q3 2026, compared with $6.4 million a year earlier.
Emergent BioSolutions (EBS) Tax Provisions (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Emergent BioSolutions' Tax Provisions was $20.7 million through Sep 30, 2026, down 31.0% year-over-year; for FY2025, it came in at $30.2 million, down 36.7% from FY2024.
- Tax Provisions shows a five-year compound annual growth rate of -22.2% (FY2020 to FY2025).
- In earlier years, Tax Provisions was $47.7 million in FY2024 (+62.8%), $29.3 million in FY2023, -$7.4 million in FY2022 and $83.7 million in FY2021 (-21.1%).
- The Q3 2026 figure marks the lowest quarterly Tax Provisions since Q2 2025.
- Compared with a year earlier, Tax Provisions was higher in two of the last four quarters, with growth averaging 138.0%.
- The best year-over-year quarter for Tax Provisions over five years was Q1 2025 (growth of 696.8%); the worst was Q4 2022 (a decline of 92.9%).
- Per Business Quant data, EBS's Tax Provisions in the three quarters before Q3 2026 was $13.9 million (Q2 2026), $6.6 million (Q1 2026) and $3.9 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 1.96 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -176.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 609.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 492.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.01 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 291.00 Mn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 822.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 634.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 134.00 Mn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | -3.70 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3.70 Mn |
| Jun 30, 2026 | 13.90 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Mar 31, 2025 | 24.70 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 27.60 Mn |
| Jun 30, 2024 | 13.30 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | -5.00 Mn |
| Sep 30, 2023 | -2.50 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Mar 31, 2023 | 25.60 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 19.90 Mn |
| Jun 30, 2022 | -26.40 Mn |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | 78.40 Mn |
Emergent BioSolutions Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=EBS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();